Therapy-related acute myeloid leukemia after successful therapy for acute promyelocytic leukemia with t(15;17): A case report and literature review.
Bao
Li
L
Lu
Xijing
X
Lai
Yueyun
Y
Zhang
Xiaohui
X
Zhu
Honghu
H
Liu
Yanrong
Y
Qin
Yazhen
Y
Huang
Xiao-Jun
XJ
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects; D002884:Chromosomes, Human, Pair 15 / Q000235:genetics*; D002886:Chromosomes, Human, Pair 17 / Q000235:genetics*; D020732:Cytogenetic Analysis; D017809:Fatal Outcome; D005434:Flow Cytometry; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D007948:Leukemia, Monocytic, Acute / Q000139:chemically induced* / Q000175:diagnosis / Q000235:genetics; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D008297:Male; D016609:Neoplasms, Second Primary / Q000139:chemically induced* / Q000175:diagnosis / Q000235:genetics; D015514:Oncogene Proteins, Fusion / Q000235:genetics; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014178:Translocation, Genetic / Q000235:genetics*; D014212:Tretinoin / Q000009:adverse effects
D000970:Antineoplastic Agents; D015514:Oncogene Proteins, Fusion; D012333:RNA, Messenger; C093476:promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein; D014212:Tretinoin